top of page
OnsiteGene Receives FDA Emergency Use Authorization (EUA) for Hi-Sense COVID-19 Molecular Testing Kit 1.0 Test

OnsiteGene Inc. is a biomedical technology company spearheading the new era of super-fast on-site genetic testing in minutes based on a novel integrated sample prep and qPCR process. OnsiteGene is located in San Diego, California, USA.

OnsiteGene's inventions include superfast nucleic acid amplification and extraction technologies. It is in the process of manufacturing and marketing various genetic analyzers including XDive™ (a superfast qPCR platform) and related testing kits. 


OnsiteGene's swiftly and precisely obtained results would take Point-of-care Testing (POCT) and routine lab testing in hospitals to the next level, making a plethora of novel applications and business models possible. 

Our Vision

OnsiteGene's vision is to enable “near-instant” and accurate on-site disease testing that leads to immediate precision treatment in a clinic.

The Problem

The demand for fast responses is a recurring theme in our society and human nature, and explains phenomena such as the proliferation of mobile communication and other internet based services. However, such a fast-response culture has yet to completely manifest itself within the healthcare industry, notably in aspects such as clinical testing, disease treatment, or other biological sample testing.
OnsiteGene is a biomedical technology company aiming at eliminating patients’ inability to obtain accurate test results in a clinic on their first visit and make it a reality for a patient to receive immediate specific drug prescription and precision medical treatment on-site without making another trip or exposing to wrong drug prescription or wrong treatment.

Any Questions?

Email us at or fill out our Contact Form. 

bottom of page